Skip to main content
Caplight Logo









Cancer Focus Fund

Cancer Focus Fund

Shreveport, Louisianacancerfocusfund.com

Overview

The firm prefers to invest in cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The firm is established in partnership with The University of Texas MD Anderson Cancer Center. Cancer focus fund is an oncology-focused investment fund which invests in compelling cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven professionals. At the Cancer Focus Fund, we invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials. Our objective is to provide support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of The University of Texas MD Anderson Cancer Center.

Year Founded

2019

Portfolio Companies

8

Investments

Cancer Focus Fund investments
CompanyDateStageLead
March BiosciencesOct 2024Series ACo-investor
KAHR MedicalJan 2026VC RoundLead
Eisbach Bio GmbHMar 2024VC RoundLead
Nectin TherapeuticsMay 2024VC RoundCo-investor
Starget PharmaFeb 2026Series ACo-investor
Book a demo to see all 8 portfolio companies

For institutional investors. Book with your work email.

Key People

Ross Barrett

General Partner

Jaime Aguirre

Partner

Jennifer Preis Pou

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Cancer Focus Fund based?

Cancer Focus Fund is headquartered in Shreveport, Louisiana, United States.

When was Cancer Focus Fund founded?

Cancer Focus Fund was founded in 2019.

How many portfolio companies does Cancer Focus Fund have?

Cancer Focus Fund has 8 portfolio companies in Caplight's dataset.

What are some companies in Cancer Focus Fund's portfolio?

Portfolio companies visible on Caplight include March Biosciences, KAHR Medical, Eisbach Bio GmbH, Nectin Therapeutics, Starget Pharma.

What was Cancer Focus Fund's most recent investment shown here?

Cancer Focus Fund's most recent investment in this portfolio sample was in Starget Pharma in 2026.

What sectors does Cancer Focus Fund focus on?

Cancer Focus Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does Cancer Focus Fund focus on?

Cancer Focus Fund typically invests at the MultiStage stage.

What is Cancer Focus Fund's AUM?

Cancer Focus Fund's assets under management are estimated between $50.0M and $100.0M.

Firmographic Details

HeadquartersShreveport, Louisiana
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?